As shown in Figures 1D, E, the level of GAMs in gliomas with wild-type IDH or without 1p19q codeletion was higher than that of gliomas with mutant IDH or with codeletion of genome 1p-19q (Figures S1D, E, H). The gene discussed is IDH2; the disease is central nervous system cancer.